US CDC panel endorses Pfizer booster shot for elderly, high-risk people
A US CDC advisory panel on Thursday endorsed booster doses of the Pfizer-BioNTech COVID-19 vaccine for Americans aged 65 and older and some adults with certain high risk conditions
 "Pfizer Vaccine, Coronavirus vaccine")
Photo: Shutterstock
A U.S. Centers for Disease Control and Prevention (CDC) advisory panel on Thursday endorsed booster doses of the Pfizer-BioNTech COVID-19 vaccine for Americans aged 65 and older and some adults with certain high risk conditions.
The panel voted 15-0 to recommend a booster dose for Americans age 65 and older and people in long term care facilities. It also fully recommended giving a single booster dose to people between the ages of 50 and 64 with certain high risk conditions, by a vote of 13-2.
On Wednesday, the Food and Drug Administration approved Pfizer boosters for people aged 65 and older or at high-risk. The extra dose would be given once they are at least six months past their last Pfizer shot.
CDC Director Rochelle Walensky is expected to accept the panel's endorsement shortly.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Sep 24 2021 | 8:56 AM IST